This one-day virtual public event explored the challenges, emerging solutions, and research opportunities around how the U.S. addresses innovation in the context of value. The forum showcased multi-stakeholder perspectives on the opportunities and challenges that innovation in biopharmaceutical, digital, diagnostic, and delivery arenas present for the science and practice of value assessment/health technology assessment.
Attendees included patient, family and caregiver organizations; employer-purchaser and payer entities; researchers; value assessors and their supporting analytical research entities; investors; policymakers; and representatives from innovators across health technology.
The 2022 IVI Methods Summit was funded by contributions from IVI’s diverse membership and a grant support from PhRMA. This project includes three components: 2022 Methods Summit public form, a one-day invitational expert roundtable, and a call for research papers that will receive IVI funding in 2023.